Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01010971Phase 3Completed
A Phase 3 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Sumitomo Pharma America. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01010971.